Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Pakistan

Drug Registration Board Partially Clears Backlog

August 2011 | Industry Trend Analysis

BMI View: Despite the significant presence of multinationals in Pakistan and the country's market potential, the leading international firms' local activity remains minimal, largely because of unfavourable operating conditions. This includes energy supply problems and security risks, as well as issues such as a poor drug approvals process and the weak enforcement of patent laws.

To read the full article, please choose one of the following options:

Subcribers please log in